Neural and Molecular Mechanisms Underlying Stress-Induced Inflammatory Responses
压力诱发炎症反应的神经和分子机制
基本信息
- 批准号:10398969
- 负责人:
- 金额:$ 53.3万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-05-01 至 2026-04-30
- 项目状态:未结题
- 来源:
- 关键词:AcuteAdrenergic AgentsAdrenergic beta-AntagonistsAffectiveAmericanAmygdaloid structureAnteriorAtherosclerosisBiologicalBiological AssayBlood specimenBrainBrain regionCardiacCardiovascular DiseasesCessation of lifeClinical TrialsComputing MethodologiesDataDevelopmentDoseDouble-Blind MethodDrug usageEconomic BurdenEtiologyEventFunctional Magnetic Resonance ImagingFutureGene ExpressionGoalsGraphHumanInflammationInflammatoryInflammatory ResponseInsula of ReilInterleukin-6InterventionKnowledgeLeadLightLinkMachine LearningMapsMathematicsMeasuresMedialMediatingMediator of activation proteinMolecularNetwork-basedOutcomePathologyPathway AnalysisPathway interactionsPatternPattern RecognitionPharmacologyPlacebo ControlPlacebosPlayProceduresPropranololProteinsPsychological StressPsychoneuroimmunologyRandomizedResearchRiskRisk FactorsRoleScanningShapesSignal PathwaySignal TransductionStressTechniquesTestingTimeUp-RegulationWorkanalytical toolattenuationbeta-adrenergic receptorcardiovascular disorder riskcomputational neurosciencecytokinedouble-blind placebo controlled trialeconomic costeconomic impacthealth economicsinflammatory markerinnovationneural circuitneural patterningneuroimagingneuromechanismnovelpreclinical studypreventrelating to nervous systemresponsesocialsocial genomicsstress reactivitystressortool
项目摘要
PROJECT SUMMARY/ABSTRACT
Cardiovascular disease (CVD) is the number one killer of Americans, and also causes significant economic costs
to the nation. Thus, understanding the mechanisms through which CVD develops is of paramount importance if
we are to successfully identify those at risk for CVD, and intervene to ultimately prevent CVD-related death and
economic impact. Psychological stress reactivity has long been appreciated as a risk factor for negative CVD-
related outcomes, and recent work suggests that inflammatory reactivity to stress is a critical biological
mechanism through which stress increases risk for CVD. However, there are significant gaps in our current
knowledge regarding the neural predictors and molecular pathways through which stress leads to inflammation.
These knowledge gaps are critical to fill if we are to develop a full mechanistic understanding of how stress leads
to CVD risk, and may also shed light on future intervention targets. Thus, the present project will use cutting-
edge computational methods to identify neural signatures of stress-related inflammatory reactivity, and will use
pharmacological tools to block an important stress-signaling pathway (i.e., beta-adrenergic signaling) and
examine its effects on neural and inflammatory reactivity to stress. Study 1 (N=100) will use fMRI to examine
neural responses to a social evaluative stress task, with blood samples taken before and after the stressor
assayed for pro-inflammatory gene expression and circulating inflammatory proteins. We will use innovative
multivariate machine learning analytic techniques to identify the neural patterns that predict changes in
inflammation, as well as network-based analytic tools from mathematics to examine how large-scale brain
networks change configuration in response to stress in ways that are linked to inflammation. In Study 2 (N=120),
we will conduct a mechanistic, randomized, double-blind, placebo-controlled trial of the beta-adrenergic receptor
blocker propranolol to examine how blocking beta-adrenergic signaling impacts neural and inflammatory
responses to the social evaluative stress task. Together, these two studies will allow us to establish the neural
signatures of stress-induced increases in inflammation (Aim 1), determine the effects of beta-adrenergic
signaling on neural responses to stress (Aim 2), and examine the neural mediators of beta-adrenergic related
attenuations in stress-related inflammatory reactivity (Aim 3). In doing so, this project will ultimately help identify
neural signatures of risk for stress-related inflammation, as well as novel targets for future intervention to
ameliorate the impact of stress on the brain and body and reduce the health and economic burden of CVD.
项目总结/摘要
心血管疾病(CVD)是美国人的头号杀手,也造成了巨大的经济损失
对国家的贡献。因此,了解CVD发展的机制至关重要,
我们要成功地识别那些有CVD风险的人,并进行干预,最终预防CVD相关的死亡,
经济影响。长期以来,心理应激反应一直被认为是负性CVD的危险因素-
最近的研究表明,对压力的炎症反应是一种关键的生物学反应,
压力增加CVD风险的机制。然而,我们目前的差距很大,
关于神经预测因子和应激导致炎症的分子途径的知识。
如果我们要对压力如何导致的问题有一个完整的机械的理解,这些知识缺口是至关重要的,
心血管疾病的风险,也可能揭示未来的干预目标。因此,本项目将使用切割-
边缘计算方法,以确定神经签名的压力相关的炎症反应,并将使用
阻断重要的应激信号传导途径的药理学工具(即,β-肾上腺素能信号传导)和
检查它对神经和炎症反应的影响。研究1(N=100)将使用fMRI检查
神经反应的社会评价压力任务,与血液样本采取之前和之后的压力
测定促炎基因表达和循环炎性蛋白。我们将使用创新的
多变量机器学习分析技术,以识别预测神经元变化的神经模式。
炎症,以及基于网络的分析工具,从数学来研究如何大规模的大脑
神经网络会改变结构以应对压力,这种方式与炎症有关。在研究2(N=120)中,
我们将对β-肾上腺素能受体进行一项机制性、随机、双盲、安慰剂对照试验,
阻断剂普萘洛尔检查阻断β-肾上腺素能信号传导如何影响神经和炎症
对社会评价压力任务的反应。这两项研究将使我们能够建立神经系统
压力诱导的炎症增加的特征(目的1),确定β-肾上腺素能受体的作用。
信号对应激神经反应的影响(目的2),并检查β-肾上腺素能相关的神经介质
减轻应激相关的炎症反应性(目的3)。通过这样做,该项目将最终帮助确定
压力相关炎症风险的神经特征,以及未来干预的新目标,
减轻压力对大脑和身体的影响,减轻心血管疾病的健康和经济负担。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Keely Ann Muscatell其他文献
Keely Ann Muscatell的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Keely Ann Muscatell', 18)}}的其他基金
Neural and Molecular Mechanisms Underlying Stress-Induced Inflammatory Responses
压力诱发炎症反应的神经和分子机制
- 批准号:
10844153 - 财政年份:2021
- 资助金额:
$ 53.3万 - 项目类别:
Neural and Molecular Mechanisms Underlying Stress-Induced Inflammatory Responses
压力诱发炎症反应的神经和分子机制
- 批准号:
10185562 - 财政年份:2021
- 资助金额:
$ 53.3万 - 项目类别:
Neural and Molecular Mechanisms Underlying Stress-Induced Inflammatory Responses
压力诱发炎症反应的神经和分子机制
- 批准号:
10608161 - 财政年份:2021
- 资助金额:
$ 53.3万 - 项目类别:
相似海外基金
Preclinical test for the efficacy of adrenergic agents in treatment of AD
肾上腺素能药物治疗AD疗效的临床前试验
- 批准号:
8358448 - 财政年份:2012
- 资助金额:
$ 53.3万 - 项目类别:
Preclinical test for the efficacy of adrenergic agents in treatment of AD
肾上腺素能药物治疗AD疗效的临床前试验
- 批准号:
8517552 - 财政年份:2012
- 资助金额:
$ 53.3万 - 项目类别:
MODULATING FLUID THERAPY WITH ADRENERGIC AGENTS AND CYCLIC AMP ENHANCERS IN
使用肾上腺素能药物和环放大器增强剂调节液体治疗
- 批准号:
7952159 - 财政年份:2009
- 资助金额:
$ 53.3万 - 项目类别:
THE EFFECT OF BETA-ADRENERGIC AGENTS AND FLUID THERAPY IN HUMANS
β-肾上腺素能药物和液体疗法对人体的影响
- 批准号:
7952152 - 财政年份:2009
- 资助金额:
$ 53.3万 - 项目类别:
MODULATING FLUID THERAPY WITH ADRENERGIC AGENTS AND CYCLIC AMP ENHANCERS IN
使用肾上腺素能药物和环放大器增强剂调节液体治疗
- 批准号:
7719194 - 财政年份:2008
- 资助金额:
$ 53.3万 - 项目类别:
THE EFFECT OF BETA-ADRENERGIC AGENTS AND FLUID THERAPY IN HUMANS
β-肾上腺素能药物和液体疗法对人体的影响
- 批准号:
7605416 - 财政年份:2007
- 资助金额:
$ 53.3万 - 项目类别:
MODULATING FLUID THERAPY WITH ADRENERGIC AGENTS AND CYCLIC AMP ENHANCERS IN
使用肾上腺素能药物和环放大器增强剂调节液体治疗
- 批准号:
7605425 - 财政年份:2007
- 资助金额:
$ 53.3万 - 项目类别:
THE EFFECT OF BETA-ADRENERGIC AGENTS AND FLUID THERAPY IN HUMANS
β-肾上腺素能药物和液体疗法对人体的影响
- 批准号:
7378753 - 财政年份:2006
- 资助金额:
$ 53.3万 - 项目类别:
Adrenergic Agents for Methamphetamine: Outpatient Trials
甲基苯丙胺肾上腺素药物:门诊试验
- 批准号:
6825160 - 财政年份:2004
- 资助金额:
$ 53.3万 - 项目类别:
ADRENERGIC AGENTS FOR CARDIOPULMONARY RESUSCITATION
用于心肺复苏的肾上腺素能药物
- 批准号:
2702283 - 财政年份:1997
- 资助金额:
$ 53.3万 - 项目类别:














{{item.name}}会员




